MVM Partners

Exciting News! Gynesonics, Inc. is now a part of Hologic, Inc. The Sonata System is an incredible addition to the Hologic gynecological portfolio, expanding access and providing women more treatment options for fibroids and abnormal uterine bleeding. Our shared commitment to women's health enables us to impact more women around the world with individualized and comprehensive treatment options. Read the full press release: https://lnkd.in/e35xkPKa Follow Hologic on Linkedin: https://lnkd.in/gCtCqhgx #BetterIsPossible #BetterTogether Hologic, Inc.

As 2024 draws to a close, we have been reflecting on a year full of opportunities, challenges and wonderful successes. It has been a monumental year for eXmoor that would not have been possible without the hard work, commitment and dedication of our entire team. Here are just a few of our highlights of 2024 … #endofyear #timetocelebrate #celltherapy #genetherapy #cheers

🚀🚀🚀 “The company is growing rapidly and has established OSSIOfiber implants as a differentiated and disruptive medical technology with clear patient benefits and passionate surgeon users. We are pleased to support OSSIO’s efforts to evolve the practice of orthopedic surgery.” - Ryan Drant, Questa This funding will enhance patient access to metal-free OSSIOfiber® implants, grow our salesforce, expand surgeon training programs, establish U.S.-based manufacturing to meet increasing demand, and advance our mission to drive Orthopedics toward biological fixation solutions. Read the Press Release linked to learn how OSSIO is changing the future of fixation. #OSSIO #Biointegration #SportsMedicine #Orthopedics #OSSIOfiber #FootAndAnkle #MedicalDevices #Innovation #Fundraising #DontSettleForMetal

📣 PRESS RELEASE - eXmoor and Virica Biotech receive funding to improve AAV gene therapy manufacturing 📣 We are delighted to announce this collaborative Canada-UK project aimed at improving the manufacture of adeno-associated vectors (#AAV), a crucial component of #genetherapies. We will utilize Virica’s VSEs™, small molecules that have been shown to increase productivity of AAVs, leveraging our scale-up and process development expertise to identify top candidates and deploy them at commercial scale upon completion of the project next year. “We thank Innovate UK for supporting this project, which we believe will benefit not only our work but our entire industry – and most importantly, patients,” said Angela Osborne “The advisory services and funding provided by the National Research Council Canada / Conseil national de recherches Canada Industrial Research Assistance Program and our partnership with eXmoor create a great commercial opportunity to increase efficiency and reduce costs of life-saving therapies,” said Jean-Simon Diallo, co-founder and CEO of Virica Read the full press release below. https://lnkd.in/eCjf55tV

Congratulations to MVM portfolio company Gynesonics, Inc. on its agreement to be acquired by Hologic, Inc.! https://lnkd.in/ePBMhwTe

News! We are pleased to announce that we have signed a definitive agreement to acquire Gynesonics, a developer of minimally invasive solutions for women’s health. Read more here: https://ow.ly/NJzZ50TKO3Y.

Gynesonics, Inc. is addressing a major unmet need in the treatment of uterine fibroids with its incisionless Sonata procedure, offering hope to millions of poorly-treated women. I feel confident that Hologic, Inc. can expand the availability of this remarkable procedure to women across the U.S. and globe. It has been a pleasure working with Skip Baldino, Robert Brown, MBA, CPA, and the entire talented, dedicated and passionate team at Gynesonics, Inc. https://lnkd.in/eBxCc2zc

Congratulations to eXmoor Pharma on its GMP manufacturing partnership with Quell Therapeutics to advance its cell therapy pipeline. https://lnkd.in/eVvQ7T-U

Exciting news for MVM portfolio company Vertos! https://lnkd.in/dWhHxq8p

https://lnkd.in/eQx5dTsV